Skip to main content
SpringerLink
Log in

Nivolumab

Aggravation of diabetes: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Matsumura K, et al. Aggravation of diabetes, and incompletely deficient insulin secretion in a case with type 1 diabetes-resistant human leukocyte antigen DRB1*15:02 treated with nivolumab. Journal of Diabetes Investigation 9: 438-441, No. 2, Mar 2018. Available from: URL: http://doi.org/10.1111/jdi.12679 -Japan

    Article  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nivolumab. Reactions Weekly 1696, 274 (2018). https://doi.org/10.1007/s40278-018-44462-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-44462-3

Search

Navigation